Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Cash & Equivalents (2017 - 2020)

enVVeno Medical has reported Cash & Equivalents over the past 4 years, most recently at $5.6 million for Q3 2020.

  • Quarterly results put Cash & Equivalents at $5.6 million for Q3 2020, up 91.24% from a year ago — trailing twelve months through Sep 2020 was $5.6 million (up 91.24% YoY), and the annual figure for FY2019 was $1.3 million, down 52.3%.
  • Cash & Equivalents for Q3 2020 was $5.6 million at enVVeno Medical, up from $1.6 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for NVNO hit a ceiling of $5.9 million in Q2 2018 and a floor of $15916.0 in Q2 2017.
  • Median Cash & Equivalents over the past 4 years was $2.2 million (2018), compared with a mean of $2.4 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 37236.16% in 2018 and later crashed 73.84% in 2020.
  • enVVeno Medical's Cash & Equivalents stood at $77688.0 in 2017, then skyrocketed by 3427.76% to $2.7 million in 2018, then plummeted by 52.3% to $1.3 million in 2019, then soared by 330.61% to $5.6 million in 2020.
  • The last three reported values for Cash & Equivalents were $5.6 million (Q3 2020), $1.6 million (Q2 2020), and $720131.0 (Q1 2020) per Business Quant data.